The Interaction Between Sex and Thyroid Cancer Development and Management.
1/5 보강
This article explores the sex difference in incidence and progression of differentiated thyroid cancer (DTC).
APA
Kitana FI, Shobab L (2025). The Interaction Between Sex and Thyroid Cancer Development and Management.. Endocrinology and metabolism clinics of North America, 54(3), 483-495. https://doi.org/10.1016/j.ecl.2025.03.016
MLA
Kitana FI, et al.. "The Interaction Between Sex and Thyroid Cancer Development and Management.." Endocrinology and metabolism clinics of North America, vol. 54, no. 3, 2025, pp. 483-495.
PMID
40716901 ↗
Abstract 한글 요약
This article explores the sex difference in incidence and progression of differentiated thyroid cancer (DTC). The article examines epidemiologic studies highlighting sex disparities in survival rates between men and women, with women experiencing a more favorable prognosis before menopause. It also discusses the role of sex hormones, genetic and epigenetic factors, and the immune system as potential contributors to the underlying mechanism of sex difference in DTC. The article advocates for sex-specific research to better understand the molecular mechanisms behind these observed sex differences and to develop targeted, sex-specific, and more individualized therapies for advanced, radioactive iodine refractory thyroid cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.